SEC Form 4 · accession 0001093557-26-000147
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas Augustinos
Director
Period of report
Aug 12, 2026
Accepted (ET)
Aug 13, 2026 · 6:38 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 12, 2026 | G | 1,075 | $0.00 | D | 37,382 | I | by Trust |
| Common StockF3 | holding | — | — | — | 5,575 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a donation of shares to a charitable donor advised fund.
- F2Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the Reporting Person is a trustee.
- F3Represents unvested restricted stock units which were granted on May 28, 2026 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders.